Atul Deodhar, M.D., M.R.C.P., FACR, FACP

  • Professor of Medicine, Division of Arthritis and Rheumatic Diseases, School of Medicine
  • Medical Director, Rheumatology Clinics, Immunology infusion center, and home infusion program, Medicine, Division of Arthritis and Rheumatic Diseases, School of Medicine

Biography

Atul A. Deodhar, MD, is Professor of Medicine and Medical Director of rheumatology clinics at the Division of Arthritis & Rheumatic Diseases in Oregon Health & Science University, Portland. He is Board Certified in Internal Medicine and Rheumatology; and is a fellow of the American College of Rheumatology, and also American College of Physicians. 

Dr. Deodhar is a past-chair of SPARTAN (Spondyloarthritis Research and Treatment Network), an organization of North American Rheumatologists dedicated to education and research in the field of axial spondyloarthritis.  He serves on the Steering Committee of GRAPPA (Group for the Research and Assessment of Psoriasis and Psoriatic Arthritis). He served on the American College of Rheumatology’s (ACR) treatment guidelines sub-committee, and as the associate editor of the Advanced Rheumatology Course by Association of Health Professionals in Rheumatology (ARHP). He has served the ACR in various other capacities as a vice chair of the annual meeting planning committee, member of the peripheral MRI task force, Association of Rheumatology Health Professionals (ARHP) nominating committee and developer of the ARHP online advanced rheumatology course.  Dr. Deodhar has served on the Rheumatology Board of the American Board of Internal Medicine (ABIM)

Dr. Deodhar is the Editor-in-Chief of Best Practice and Research Clinical Rheumatology, and has been a guest editor for Current Opinion in Rheumatology.  He is a reviewer for the New England Journal of Medicine, Lancet, Arthritis & Rheumatology, Annals of the Rheumatic Diseases, Annals of Internal Medicine, among several other journals. His research interests are axial spondyloarthritis, and psoriatic arthritis.  He has authored 3 books, over 300 peer-reviewed articles; several book chapters, and editorials. Dr. Deodhar has been He has been a principal or co-investigator in more than 100 clinical trials, mostly focused on therapies for ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis.

He completed his fellowship in rheumatology at Oregon Health & Science University, and before that, a research fellowship in rheumatology at the Royal Cornwall Hospital, Truro, England.  He completed his residency in internal medicine and geriatrics at the Royal Cornwall Hospital, Truro, as well as in the Sassoon General Hospital and King Edward Memorial Hospital, Pune, India.  He received his MBBS and MD degrees from the University of Pune, India; and the MRCP from the Royal College of Physicians, London, England.

Education and training

  • Degrees

    • M.B.B.S., 1980, B.J. Medical College
    • M.D., 1984, University of Pune
    • M.R.C.P., 1990, Royal College of Physicians
    • M.D., 1996, University of Bath

  • Residency

    • KEM Hospital, Pune, India

  • Fellowship

    • Rheumatology: Royal Cornwall Hospital, Truro, England
    • Oregon Health and Science University, Portland, Oregon

  • Certifications

    • American Board of Internal Medicine - Internal Medicine
    • American Board of Internal Medicine - Rheumatology

Memberships and associations:

  • Member, Royal College of Physicians, London, England; M.D. (Ph.D. equivalent), University of Bath, England
  • American College of Rheumatology
  • Fellow of American College of Rheumatology
  • Fellow of American College of Physicians
  • Spondyloarthritis Research and Treatment Network - SPARTAN
  • Group for the research and assessment of Psoriasis and Psoriatic Arthritis - GRAPPA

Areas of interest

  • Axial Spondyloarthritis
  • Psoriatic Arthritis

Honors and awards

  • OHSU Teaching Award, 2018

Publications

Elsevier pure profile

Publications

  • Efficacy and Safety of Intravenous Secukinumab in Patients With Active Axial Spondyloarthritis

    Arthritis and Rheumatology
    1. Atul Deodhar
    2. Jerzy Supronik
    3. Alan Kivitz
    4. Guillermo Valenzuela
    5. Karen Kapur
    6. Susanne Rohrer
    7. Eva Dokoupilová
    8. Hanno B. Richards
    9. Karel Pavelka

  • Improved Pain, Morning Stiffness, and Fatigue With Bimekizumab in Axial Spondyloarthritis

    Journal of Rheumatology
    1. Victoria Navarro-Compán
    2. Martin Rudwaleit
    3. Maureen Dubreuil
    4. Marina Magrey
    5. Helena Marzo-Ortega
    6. Philip J. Mease
    7. Jessica A. Walsh
    8. Maxime Dougados
    9. Christine de la Loge
    10. Carmen Fleurinck
    11. Ute Massow
    12. Thomas Vaux
    13. Vanessa Taieb
    14. Atul Deodhar

  • Upadacitinib in active non-radiographic axial spondyloarthritis

    Arthritis Research and Therapy
    1. Filip Van den Bosch
    2. Atul Deodhar
    3. Denis Poddubnyy
    4. Walter P. Maksymowych
    5. Désirée van der Heijde
    6. Tae Hwan Kim
    7. Mitsumasa Kishimoto
    8. Xenofon Baraliakos
    9. Xianwei Bu
    10. Ivan Lagunes-Galindo
    11. In Ho Song
    12. Peter Wung
    13. Koji Kato
    14. Anna Shmagel

  • Advances in Psoriatic Disease Research

    Journal of Rheumatology
    1. Ashley Elliott
    2. Tejpal Gill
    3. Jaehwan Kim
    4. Maria S. Shutova
    5. Oliver FitzGerald
    6. Stephen R. Pennington
    7. Madeleine Rooney
    8. Atul Deodhar
    9. Siba P. Raychaudhuri
    10. Wolf Henning Boehncke
    11. Kurt de Vlam
    12. Vinod Chandran
    13. Wilson Liao

  • Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis

    Clinical Rheumatology
    1. Proton Rahman
    2. Iain B. McInnes
    3. Atul Deodhar
    4. Georg Schett
    5. Phillip J. Mease
    6. May Shawi
    7. Daniel J. Cua
    8. Jonathan P. Sherlock
    9. Alexa P. Kollmeier
    10. Xie L. Xu
    11. Shihong Sheng
    12. Christopher T. Ritchlin
    13. Dennis McGonagle

  • Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains

    RMD open
    1. Victoria Navarro-Compán
    2. Sofia Ramiro
    3. Atul Deodhar
    4. Philip J. Mease
    5. Martin Rudwaleit
    6. Christine De La Loge
    7. Carmen Fleurinck
    8. Vanessa Taieb
    9. Michael F. Mørup
    10. Ute Massow
    11. Jonathan Kay
    12. Marina Magrey

  • Bimekizumab treatment in patients with active axial spondyloarthritis

    Annals of the rheumatic diseases
    1. Xenofon Baraliakos
    2. Atul Deodhar
    3. Désirée van der Heijde
    4. Marina Magrey
    5. Walter P. Maksymowych
    6. Tetsuya Tomita
    7. Huji Xu
    8. Ute Massow
    9. Carmen Fleurinck
    10. Alicia M. Ellis
    11. Thomas Vaux
    12. Julie Shepherd-Smith
    13. Alexander Marten
    14. Lianne S. Gensler

  • Breakout Session and Report Back

    Journal of Rheumatology
    1. Daniela Kampel Stolnicki
    2. Laura C. Coates
    3. Charlotte E. Gollins
    4. Sahil Koppikar
    5. Lourdes M. Perez-Chada
    6. Luís Puig
    7. Alexis Ogdie
    8. Atul Deodhar
    9. Christopher Ritchlin
    10. Samuel T. Hwang
    11. Claudia Goldenstein-Schainberg

  • Comparative efficacy and safety of bimekizumab in axial spondyloarthritis

    Rheumatology (United Kingdom)
    1. Atul Deodhar
    2. Pedro M. Machado
    3. Michael Mørup
    4. Vanessa Taieb
    5. Damon Willems
    6. Michelle Orme
    7. David Pritchett
    8. Lianne S. Gensler

  • Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics

    Clinical Rheumatology
    1. Christopher T. Ritchlin
    2. Philip J. Mease
    3. Wolf Henning Boehncke
    4. John Tesser
    5. Soumya D. Chakravarty
    6. Emmanouil Rampakakis
    7. May Shawi
    8. Elena Schiopu
    9. Joseph F. Merola
    10. Iain B. McInnes
    11. Atul Deodhar

  • Early Improvements with Guselkumab Associate with Sustained Control of Psoriatic Arthritis

    Rheumatology and Therapy
    1. Jeffrey R. Curtis
    2. Atul Deodhar
    3. Enrique R. Soriano
    4. Emmanouil Rampakakis
    5. May Shawi
    6. Natalie J. Shiff
    7. Chenglong Han
    8. William Tillett
    9. Dafna D. Gladman

  • Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis

    Arthritis and Rheumatology
    1. Xenofon Baraliakos
    2. Mikkel Østergaard
    3. Denis Poddubnyy
    4. Désirée van der Heijde
    5. Atul Deodhar
    6. Pedro M. Machado
    7. Victoria Navarro-Compán
    8. Kay Geert A. Hermann
    9. Mitsumasa Kishimoto
    10. Eun Young Lee
    11. Lianne S. Gensler
    12. Uta Kiltz
    13. Marco F. Eigenmann
    14. Patricia Pertel
    15. Aimee Readie
    16. Hanno B. Richards
    17. Brian Porter
    18. Juergen Braun

  • Efficacy and Safety of Tofacitinib in Ankylosing Spondylitis by Baseline C-Reactive Protein Level

    Journal of Rheumatology
    1. Atul Deodhar
    2. Xenofon Baraliakos
    3. Marina Magrey
    4. Lianne S. Gensler
    5. Amit V. Thorat
    6. Surya Kiran Pemmaraju
    7. Mary Jane Cadatal
    8. Peter Nash

  • Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis refractory to biologic therapy

    Arthritis Research and Therapy
    1. Xenofon Baraliakos
    2. Désirée van der Heijde
    3. Joachim Sieper
    4. Robert Davies Inman
    5. Hideto Kameda
    6. Walter Peter Maksymowych
    7. Ivan Lagunes-Galindo
    8. Xianwei Bu
    9. Peter Wung
    10. Koji Kato
    11. Anna Shmagel
    12. Atul Deodhar

  • Guselkumab in Biologic-Naïve Patients with Active Psoriatic Arthritis in Russia

    Rheumatology and Therapy
    1. Philip Mease
    2. Tatiana Korotaeva
    3. Pavel Shesternya
    4. Muza Kokhan
    5. Anton Rukavitsyn
    6. Dmitry Vasilchenkov
    7. Mohamed Sharaf
    8. Frédéric Lavie
    9. Atul Deodhar

  • Improved physical functioning, sleep, work productivity and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis

    RMD open
    1. Maureen Dubreuil
    2. Victoria Navarro-Compán
    3. Annelies Boonen
    4. Karl Gaffney
    5. Lianne S. Gensler
    6. Christine De La Loge
    7. Thomas Vaux
    8. Carmen Fleurinck
    9. Ute Massow
    10. Vanessa Taieb
    11. Michael F. Mørup
    12. Atul Deodhar
    13. Martin Rudwaleit

  • Improvements in Patient-Reported Outcomes After Treatment With Deucravacitinib in Patients With Psoriatic Arthritis

    Arthritis Care and Research
    1. Vibeke Strand
    2. Laure Gossec
    3. Laura C. Coates
    4. Alexis Ogdie
    5. Jiyoon Choi
    6. Brandon Becker
    7. Joe Zhuo
    8. Thomas Lehman
    9. Miroslawa Nowak
    10. Ayanbola Elegbe
    11. Philip J. Mease
    12. Atul Deodhar

  • Integrated safety analysis of tofacitinib from Phase 2 and 3 trials of patients with ankylosing spondylitis

    Advances in Rheumatology
    1. Atul Deodhar
    2. Servet Akar
    3. Jeffrey R. Curtis
    4. Bassel El-Zorkany
    5. Marina Magrey
    6. Cunshan Wang
    7. Joseph Wu
    8. Solomon B. Makgoeng
    9. Ivana Vranic
    10. Sujatha Menon
    11. Dona L. Fleishaker
    12. Annette M. Diehl
    13. Lara Fallon
    14. Arne Yndestad
    15. Robert B.M. Landewé

  • Long-term clinical outcomes of certolizumab pegol treatment in nonradiographic axial spondyloarthritis stratified by baseline MRI and CRP status

    RMD open
    1. Martin Rudwaleit
    2. Atul Deodhar
    3. Lars Bauer
    4. Lianne Gensler
    5. Bengt Hoepken
    6. Thomas Kumke
    7. Simone Emanuele Auteri
    8. Mindy Kim
    9. Walter Maksymowych

  • Long-Term Safety of Guselkumab in Patients with Psoriatic Disease

    Drug Safety
    1. Bruce Strober
    2. Laura C. Coates
    3. Mark G. Lebwohl
    4. Atul Deodhar
    5. Evan Leibowitz
    6. Katelyn Rowland
    7. Alexa P. Kollmeier
    8. Megan Miller
    9. Yanli Wang
    10. Shu Li
    11. Soumya D. Chakravarty
    12. Daphne Chan
    13. May Shawi
    14. Ya Wen Yang
    15. Diamant Thaҫi
    16. Proton Rahman

  • Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis

    Arthritis Research and Therapy
    1. Atul Deodhar
    2. Andrew Blauvelt
    3. Mark Lebwohl
    4. Meghan Feely
    5. Andris Kronbergs
    6. Nadezhda Eberhart
    7. Danting Zhu
    8. Elsa Inman
    9. Elsie Grace
    10. Thorsten Holzkaemper
    11. Proton Rahman
    12. Helena Marzo-Ortega
    13. Kim A. Papp
    14. Joseph F. Merola
    15. Alice B. Gottlieb
    16. Sergio Schwartzman

  • Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab

    Annals of the rheumatic diseases
    1. Matthew A. Brown
    2. Martin Rudwaleit
    3. Floris A. Van Gaalen
    4. Nigil Haroon
    5. Lianne S. Gensler
    6. Carmen Fleurinck
    7. Alexander Marten
    8. Ute Massow
    9. Natasha De Peyrecave
    10. Thomas Vaux
    11. Katy White
    12. Atul Deodhar
    13. Irene Van Der Horst-Bruinsma

  • Modulation of Interleukin-23 Signaling With Guselkumab in Biologic-Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis

    Arthritis and Rheumatology
    1. Stefan Siebert
    2. Laura C. Coates
    3. Georg Schett
    4. Siba P. Raychaudhuri
    5. Warner Chen
    6. Sheng Gao
    7. Loqmane Seridi
    8. Soumya D. Chakravarty
    9. May Shawi
    10. Frederic Lavie
    11. Mohamed Sharaf
    12. Miriam Zimmermann
    13. Alexa P. Kollmeier
    14. Xie L. Xu
    15. Proton Rahman
    16. Philip J. Mease
    17. Atul Deodhar

  • Persistent Patient-Level Effect of Guselkumab at Consecutive 8-Week Dosing Visits and Over Time in Patients With Active Psoriatic Arthritis

    ACR Open Rheumatology
    1. Philip J. Mease
    2. Xenofon Baraliakos
    3. Vinod Chandran
    4. Enrique R. Soriano
    5. Peter Nash
    6. Atul Deodhar
    7. Emmanouil Rampakakis
    8. Natalie J. Shiff
    9. Soumya D. Chakravarty
    10. May Shawi
    11. Joseph F. Merola
    12. Iain B. McInnes